BMN 673-13C,15N2
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
BMN 673-13C,15N2 Product Information
BMN 673-13C,15N2 is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-100754.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
BMN 673-13C,15N2
CAT No.
CS-T-100754
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C1813CH14F2N415N2O
Molecular Weight
383.33
Category
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
BMN 673-13C,15N2 is supplied with detailed characterization data compliant with regulatory guideline. BMN 673-13C,15N2 can be used for analytical method development, method validation (AMV), Quality Control (QC), ANDA-related analytical work, and commercial pharmaceutical research applications.
Overview
"BMN 673-13C,15N2 is the isotope labelled analog of BMN 673 (B595895); a pyrrolopyrazine derivative and anpoly (ADP-ribose) polymerase (PARP) inhibitor for patients with advanced or recurrent solid tumors such as ovarian and breast cancer."
Synonyms
BMN 673-13C,15N2
Application Notes
"BMN 673-13C,15N2 is the isotope labelled analog of BMN 673 (B595895); a pyrrolopyrazine derivative and anpoly (ADP-ribose) polymerase (PARP) inhibitor for patients with advanced or recurrent solid tumors such as ovarian and breast cancer."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.